share_log

Scilex Provides Information To Stockholders Regarding Manipulative And Naked Short Selling Of Its Common Stock

Scilex Provides Information To Stockholders Regarding Manipulative And Naked Short Selling Of Its Common Stock

Scilex向股東提供有關其普通股的操縱性和赤裸賣空的信息
Benzinga ·  05/13 21:08

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today provides information to its stockholders regarding short selling of Scilex common stocks traded on the Nasdaq Capital Market.

Scilex Holding Company(納斯達克股票代碼:SCLX,“Scilex” 或 “公司”))))是一家創新的創收公司,專注於收購、開發和商業化用於治療急慢性疼痛的非阿片類疼痛管理產品,今天向其股東提供有關在納斯達克資本市場交易的Scilex普通股賣空的信息。

According to credible information available to Scilex, Scilex management believes there are approximately 10 million share of Scilex common stock being sold short and additionally, there are more than 10 million Dividend Shares deemed to have been sold as "naked short" positions on or after January 2023 that have not been covered as of today. The Company believes that there are substantial "naked short" positions in approximately 44 million shares of its common stock that had not cast votes based on the reports tabulated by Broadridge Financial Solutions, Inc., an independent third party that collects and tabulates stockholder votes, for the Company's prior two annual meetings for its stockholders. This represents a failure by the brokerage firms to deliver the Dividend Shares for approximately 15 months constituting a potential violation of Regulation SHO.

根據Scilex獲得的可靠信息,Scilex管理層認爲,大約有1000萬股的Scilex普通股被賣空,此外,還有超過1000萬股股息股票在2023年1月當天或之後被視爲 “裸空頭” 頭寸出售,但截至今天尚未兌現。根據負責收集和列出股東選票的獨立第三方Broadridge Financial Solutions, Inc. 在公司前兩次股東年會中提交的報告,該公司認爲,其約4,400萬股普通股中存在大量未投票的 “裸空頭” 頭寸。這表示經紀公司在大約15個月內未能交付股息股票,這可能違反了SHO法規。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論